Scan how other consulting and IT services stocks are reacting to the same AI and bond market cross-currents by reviewing our curated list of list of solid balance sheet and fundamentals (23 results).
The core belief for holding Nomura Research Institute is that its consulting and IT solutions can keep winning long term projects with financial and industrial clients, while the IT platform services arm supports that demand. The short term catalyst is execution on this mix after a year where profit margins softened to 2.2%, well below the prior 12.6% level.
The sharp gain on an AI risk off day looks more sentiment driven than business changing. It does not alter the key risk right now, which is profit pressure meeting a volatile share price profile and a relatively high P/S versus the broader JP IT industry, even as earnings are forecast to grow quickly.
There were no fresh corporate announcements tied directly to the move on 9 October 2026, so the trading reaction mainly sits against the existing earnings and balance sheet story. What matters more for you is how Nomura Research Institute turns its ¥829.4b in revenue and ¥18.5b in net income into sturdier profitability from here.
For catalysts, analysts currently expect earnings to rise much faster than revenue, with forecasts pointing to 25.5% yearly profit growth compared with 5.5% top line growth. That gap puts a spotlight on cost control, pricing on large IT contracts, and capital allocation, particularly since funding is entirely through external borrowing rather than customer deposits.
Nomura Research Institute's current earnings of ¥18.5b are set against analyst assumptions that revenue will grow at 5.8% per year and that consensus profits will reach ¥153.0b by 2029. This implies an earnings increase of about 8x from today and aligns with forecasts for ¥983.5b in revenue in that same year.
Uncover why Nomura Research Institute's fair value indicates a 5% potential upside to its current price that may not last much longer.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the recent move in Nomura Research Institute has sharpened your focus on where to deploy fresh capital next, casting a wider net across quality stocks can help you stress test your thesis and avoid anchoring on a single ticker.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com